IRCT20101104005101N2已完成3 期
Evaluation of Ki67 factor changes after 7 days treatment with Letrozol in postmenopausal women with an early stage breast cancer and hormone receptor positive
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- Female
入选标准
- •Breast caner patients
- •Early stage of disease
- •With hormone receptor positive
- •Postmenopausal women
排除标准
- •Metastatic breast cancer
- •Premenopausal women
- •Other sub-types of breast cancer
研究者
相似试验
招募中
不适用
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before SurgeryBreast CancerNCT06127979Memorial Sloan Kettering Cancer Center42
招募中
3 期
Assess the efficacy of endocrine therapy preoperatively in patients who are hormone receptor positiveCTRI/2022/01/039736Amrita institute of Medical Sciences
已完成
2 期
18F-FLT-PET in Breast Cancer (MK-0000-139)Breast CancerNCT01015131Merck Sharp & Dohme LLC46
尚未招募
不适用
the association between Ki67 and clinical features in patients with advanced EGFR-positive lung adenocarcinoma40 cases diagnosed advanced lung adenocarcinoma. The 20 cases were EGFR mutation positive and treated with EGFR inhibitors, and the other 20 cases are EGFR mutation negative and treated with chemotherapy and/or immunotherapy.JPRN-UMIN000042886Tohoku Medical and Pharmaceutical University,Tohoku Medical and Pharmaceutical University Hospital40
已完成
不适用
Identification and Semi-Quantification of Ki-67 Protein Expression StatusBreast CancerNCT02654457Applied Spectral Imaging Ltd.3